Full Text
CO15 A Matching-Adjusted Indirect Comparison of Efgartigimod Versus Ravulizumab for Generalized Myasthenia Gravis

Abstract

Authors

L Celico E Spaepen M De Francesco S Chiroli S Iannazzo T Ruck SG Meuth

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×